Pharmacological Treatments for Psychotic Depression
March 22, 2024
Current treatment guidelines for psychotic depression recommend a c...
Read More
Science Update: Omega-3 Supplements May Reduce Schizotypal Personality Symptoms
March 9, 2024
A recent randomized controlled trial examined whether omega-3 fatty...
Read More
Clozapine for Aggression and Violence
March 6, 2024
A recent post-hoc analysis suggest that cariprazine is a viable tre...
Read More
Long-Acting Injectable Versus Oral Antipsychotics in Preventing Psychiatric Rehospitalizations
February 27, 2024
Individuals with schizophrenia often struggle with consistently tak...
Read More
Cross-Talk Between TrkB and mGlu
February 12, 2024
This study investigates the molecular pathways of metabotropic glut...
Read More
Do VMAT2 Inhibitors Work For Schizophrenia and Psychosis?
February 9, 2024
The core dysfunction of schizophrenia is due to an increase in pres...
Read More
TMS for Memory Impairments in Schizophrenia
December 21, 2023
A new study investigated the effects of repetitive transcranial mag...
Read More
Antipsychotic Medications and Mortality in Children and Young Adults
December 15, 2023
Children and young adults are commonly prescribed antipsychotics, p...
Read More
Substance-Induced Psychosis Tied to Schizophrenia Risk
October 17, 2023
individuals without a history of psychosis were assessed for the li...
Read More
Sexual Dysfunction in Schizophrenia
October 9, 2023
Schizophrenia has high prevalence rates of sexual dysfunction; howe...
Read More
Antipsychotic Polypharmacy Increases Risk of Hypertension, Study Suggests
September 21, 2023
In some cases, treating schizophrenia is especially difficult and m...
Read More
Schizophrenia Treatment Fails to Meet Primary Endpoint in Phase 3 Clinical Studies
August 15, 2023
Recent trials for the TAAR1 agonist ulotaront to treat schizophreni...
Read More